Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Benefits of supervised community physical activity in obstructive sleep apnoea

Mathieu Berger, Jean-Claude Barthélémy, David Hupin, Jérémy Raffin, Caroline Dupré, Pierre Labeix, Frédéric Costes, Jean-Michel Gaspoz, Frédéric Roche
European Respiratory Journal 2018 52: 1801592; DOI: 10.1183/13993003.01592-2018
Mathieu Berger
1SNA-EPIS Laboratory, EA 4607, University of Lyon, Saint-Etienne, France
2Dept of Clinical and Exercise Physiology, University Hospital of Saint-Etienne, Saint-Etienne, France
3IRAPS, Fédération Française d’Education Physique et de Gymnastique Volontaire (FFEPGV), Montreuil, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mathieu Berger
Jean-Claude Barthélémy
1SNA-EPIS Laboratory, EA 4607, University of Lyon, Saint-Etienne, France
2Dept of Clinical and Exercise Physiology, University Hospital of Saint-Etienne, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Hupin
1SNA-EPIS Laboratory, EA 4607, University of Lyon, Saint-Etienne, France
2Dept of Clinical and Exercise Physiology, University Hospital of Saint-Etienne, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jérémy Raffin
1SNA-EPIS Laboratory, EA 4607, University of Lyon, Saint-Etienne, France
2Dept of Clinical and Exercise Physiology, University Hospital of Saint-Etienne, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Dupré
1SNA-EPIS Laboratory, EA 4607, University of Lyon, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Labeix
1SNA-EPIS Laboratory, EA 4607, University of Lyon, Saint-Etienne, France
2Dept of Clinical and Exercise Physiology, University Hospital of Saint-Etienne, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédéric Costes
4Unit of Human Nutrition, INRA UMR 1019, University of Auvergne, Clermont-Ferrand, France
5Dept of Physiology, University Hospital Gabriel Montpied, Clermont-Ferrand, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Michel Gaspoz
6Division of Primary Care Medicine, Dept of Community Medicine, Primary Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédéric Roche
1SNA-EPIS Laboratory, EA 4607, University of Lyon, Saint-Etienne, France
2Dept of Clinical and Exercise Physiology, University Hospital of Saint-Etienne, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Long-term physical activity programmes outside of hospitals may help improve moderate obstructive sleep apnoea, particularly in obese patients http://ow.ly/11jg30lOJYS

To the Editor:

Obstructive sleep apnoea (OSA) is a chronic disorder characterised by repetitive episodes of partial or complete airway obstruction occurring during sleep [1]. Recent data suggest that moderate-to-severe OSA is highly prevalent, affecting up to 50% of males and 25% of females [2]. OSA is associated with frequent cardiovascular and cerebrovascular events [3]. Although continuous positive airway pressure (CPAP) is the gold standard treatment, long-term adherence remains poor, particularly in moderate and in non-sleepy patients [4], while the cardiovascular risk remains high.

Exercise has attracted attention by improving apnoea–hypopnoea index (AHI), daytime sleepiness and quality of life [5–8]. However, previous studies had several drawbacks including small sample size, too-specific populations, lack of randomisation and short-term follow-up, while OSA patients need long-term management.

Therefore, the aim of the present randomised controlled trial was to assess the effectiveness of a 9-month exercise programme undertaken outside hospital as a treatment for moderate OSA, defined by reaching an AHI <15 events·h−1 at follow-up.

Between June 2015 and September 2017, we screened 595 participants from the general population as well as 30 from the sleep laboratory of the University Hospital of Saint-Etienne (France). Eligible criteria were AHI in the range 15–30 events·h−1 and age 40–80 years. Exclusion criteria were current treatment for OSA; cardiovascular or respiratory comorbidities and/or Epworth Sleepiness Scale (ESS) score >10 justifying immediate initiation of CPAP; respiratory or heart disease contraindicating exercise discovered during stress testing; and Parkinson's disease. The study was approved by an institutional review board (CPP Sud-Est 1 #1508033, France) and registered with ClinicalTrials.gov (NCT02463890).

Eligible patients were assigned randomly to the exercise or to the control group after obtaining written informed consent. Patients randomised to the exercise group were enrolled in an exercise programme (NeuroGyV) performed in clubs of a non-competitive sports federation, the French Federation for Physical Education and Voluntary Gymnastics (FFEPGV). The programme combined three different supervised sessions of exercise per week during the 9 months of the FFEPGV annual activity: nordic walking, aquagym and gymnastics. Each session lasted 60 min, including 10 min of warm-up, 40 min of combined resistance and aerobic exercises at the anaerobic threshold and 10 min of cool-down, complying with public health recommendations. Control group participants attended two group educational sessions about healthy diet and physical activity recommendations.

All patients underwent a polygraphic recording (Nox T3; Nox Medical, Reykjavik, Iceland) at baseline and 9 months. Examinations were manually scored twice according to the 2012 American Academy of Sleep Medicine criteria [9], by a single scorer blinded to treatment assignment and OSA severity was defined as mild (5≤AHI<15 events·h−1), moderate (15≤AHI<30 events·h−1) or severe (AHI ≥30 events·h−1). A maximal cardiopulmonary exercise test (CPET) was performed on a cycloergometer including breath-by-breath respiratory gas exchange measurements (Jaeger Vyntus CPX; CareFusion, Hoechberg, Germany). Medical history was recorded and anthropometric data measured. Daytime sleepiness was assessed using the ESS and subjective sleep quality using the Pittsburgh Sleep Quality Index (PSQI); daily physical activity was evaluated using the Population Physical Activity Questionnaire [10].

With 80% power and α=0.05, 48 participants per group were required to detect a 30% treatment efficacy in the exercise group and 5% in the control group, assuming a 10% attrition rate. All analyses were conducted in intention-to-treat (ITT) using IBM-SPPS Statistics 24.0 (IBM, Armonk, NY, USA). Data are presented as mean±sd and frequencies.

We included 96 patients (mean age 63±7 years, mean body mass index (BMI) 28.5±4.2 kg·m−2, 61% male, 71% hypertensive and 19% diabetic); 88 patients completed follow-up visits at 9 months. No significant differences were observed between groups for any of the baseline characteristics. No adverse events occurred. The average exercise attendance was 61 out of the 88 prescribed sessions (median 76%, interquartile range 63–88%).

A significantly higher proportion of patients in the exercise group (25 out of 43; 58%, 95% CI 43­–74%) reached an AHI <15 events·h−1 after 9 months compared to the control group (nine out of 45; 20%, 95% CI 8–32%; Chi-squared p<0.0001). The significant effect of exercise remained after adjustment for age, sex, baseline BMI, AHI and moderate-to-vigorous physical activity (MVPA) (p<0.0001). None of the patients reached an AHI<5 events·h−1.

Compared to controls, the exercise group demonstrated a significant decrease in AHI (−18% versus +6%; p=0.007). In addition, other parameters of OSA improved in the exercise group while oxygen saturation (SpO2) parameters worsened in the control group (table 1). Supine time during sleep did not change in any group (p=0.39). Clinically, the exercise group showed a significant drop in ESS and PSQI scores compared to the control, group in which sleep quality worsened. Interestingly, the intervention effect was significantly greater in obese patients compared to patients with a BMI <30 kg·m−2 after adjustment for initial AHI (p=0.037).

View this table:
  • View inline
  • View popup
TABLE 1

Group comparisons of sleep, exercise and anthropometrics parameters at baseline and change at 9 months

Peak oxygen consumption increased in the exercise group compared to controls on CPET, along with anaerobic threshold and peak oxygen pulse (table 1). Both MVPA and total daily energy expenditure increased in the exercise group.

Although weight and BMI were stable in both groups, neck circumference increased in the control group while waist-to-hip ratio decreased in the exercise group (table 1).

Overall, we showed that 58% of the moderate OSA patients reached an AHI <15 events·h−1 in response to a 9-month supervised community physical activity programme. However, the reduction in AHI of 4.1 events·h−1 found in the ITT group with exercise was lower than previously reported. This may be explained by more severe OSA in other trials [7, 8], major obesity, or younger age [5]; some trials included dietary interventions in the exercise group [8], which may catalyse the favourable effect of exercise training. Interestingly, our per-protocol analysis demonstrated an AHI improvement reaching −6.2±7.5 events·h−1, which was consistent with results of a previous meta-analysis [11].

By contrast, OSA spontaneously increased in controls after 9 months, as evidenced by a higher time at SpO2 <90% and lower mean SpO2, two independent predictors of sudden cardiac death [12].

The strength of our trial lies in the 9-month management outside the healthcare sector as compared to previous studies designed on shorter periods in hospital settings [5, 6, 8]. It is worth noting that the improvement in maximal oxygen uptake suggests benefits in cardiovascular risk reduction and improvement of life expectancy [13], whereas recent studies have revealed that CPAP therapy alone does not prevent cardiovascular mortality [14].

The main limitation of our study was the OSA assessment on a single night upon inclusion and follow-up, which may have introduced additional variability [15], even though it remains a standard. Moreover, participants were aware of their intervention assignments and some patients randomised to the control group may have trained independently; however, this would have reduced the magnitude of the effects of the programme we observed.

Our exploratory analyses revealed that the exercise effect was greater in obese patients, suggesting a potential role of change in pharyngeal fat mass distribution through exercise training which may contribute to reduce OSA severity in obese patients, although this was not assessed in the present study.

In conclusion, long-term physical activity programmes in real-life community settings may help improve moderate OSA, although AHI improvement remains modest. Obese patients are probably the best candidates for such programmes.

Acknowledgements

We thank all the participants for their commitment and their willingness, Arnaud Garcin for study coordination, Laurent Tordella for data management, Mathilde Donnat and Hayet Iddir for their involvement in the data collection, and Audrey Laligant and Isabelle Goure (all at CHU Saint-Etienne, Saint-Etienne, France) for the diet educational group sessions. We are grateful for the involvement of the Fédération Française d’Education Physique et de Gymnastique Volontaire (FFEPGV) Loire clubs' leaders and sports instructors, which made the study possible. We thank Resmed, and the Home Care Service Company Vivisol and VitalAire for the loan of portable sleep monitoring.

Footnotes

  • This study is registered at ClinicalTrials.gov with identifier number NCT02463890. Individual participant data that underlie the results reported in this article will be shared, after de-identification.

  • Conflict of interest: M. Berger has nothing to disclose.

  • Conflict of interest: J-C. Barthélémy has nothing to disclose.

  • Conflict of interest: D. Hupin has nothing to disclose.

  • Conflict of interest: J. Raffin has nothing to disclose.

  • Conflict of interest: C. Dupré has nothing to disclose.

  • Conflict of interest: P. Labeix has nothing to disclose.

  • Conflict of interest: F. Costes has nothing to disclose.

  • Conflict of interest: J-M. Gaspoz has nothing to disclose.

  • Conflict of interest: F. Roche has nothing to disclose.

  • Support statement: Supported by grants from the National Association of Research and Technology (ANRT) and the Fédération Française d’Education Physique et de Gymnastique Volontaire (FFEPGV) through the CIFRE Convention #2014/0391, from the University Hospital of Saint-Etienne (AOL #2015/150833), and from the Adène group. The University Hospital of Saint-Etienne was the sponsor of the study. Funding information for this article has been deposited with the Crossref Funder Registry.

  • Received April 18, 2018.
  • Accepted September 5, 2018.
  • Copyright ©ERS 2018

References

  1. ↵
    Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999: 22: 667–689.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Heinzer R,
    2. Vat S,
    3. Marques-Vidal P, et al.
    Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 2015; 3: 310–318.
    OpenUrl
  3. ↵
    1. Javaheri S,
    2. Barbe F,
    3. Campos-Rodriguez F, et al.
    Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol 2017; 69: 841–858.
    OpenUrlFREE Full Text
  4. ↵
    1. Pelletier-Fleury N,
    2. Rakotonanahary D,
    3. Fleury B
    . The age and other factors in the evaluation of compliance with nasal continuous positive airway pressure for obstructive sleep apnea syndrome. A Cox's proportional hazard analysis. Sleep Med 2001; 2: 225–232.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Kline CE,
    2. Crowley EP,
    3. Ewing GB, et al.
    The effect of exercise training on obstructive sleep apnea and sleep quality: a randomized controlled trial. Sleep 2011; 34: 1631–1640.
    OpenUrlPubMedWeb of Science
  6. ↵
    1. Sengul YS,
    2. Ozalevli S,
    3. Oztura I, et al.
    The effect of exercise on obstructive sleep apnea: a randomized and controlled trial. Sleep Breath 2011; 15: 49–56.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Mendelson M,
    2. Lyons OD,
    3. Yadollahi A, et al.
    Effects of exercise training on sleep apnoea in patients with coronary artery disease: a randomised trial. Eur Respir J 2016; 48: 142–150.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Desplan M,
    2. Mercier J,
    3. Sabaté M, et al.
    A comprehensive rehabilitation program improves disease severity in patients with obstructive sleep apnea syndrome: a pilot randomized controlled study. Sleep Med 2014; 15: 906–912.
    OpenUrl
  9. ↵
    1. Berry RB,
    2. Budhiraja R,
    3. Gottlieb DJ, et al.
    Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012; 8: 597–619.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Garet M,
    2. Degache F,
    3. Costes F, et al.
    DAQIHF: methodology and validation of a daily activity questionnaire in heart failure. Med Sci Sports Exerc 2004; 36: 1275–1282.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Iftikhar IH,
    2. Kline CE,
    3. Youngstedt SD
    . Effects of exercise training on sleep apnea: a meta-analysis. Lung 2014; 192: 175–184.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Gami AS,
    2. Olson EJ,
    3. Shen WK, et al.
    Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 2013; 62: 610–616.
    OpenUrlFREE Full Text
  13. ↵
    1. Myers J,
    2. Prakash M,
    3. Froelicher V, et al.
    Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793–801.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. McEvoy RD,
    2. Antic NA,
    3. Heeley E, et al.
    CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016; 375: 919–931.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Levendowski DJ,
    2. Zack N,
    3. Rao S, et al.
    Assessment of the test-retest reliability of laboratory polysomnography. Sleep Breath 2009; 13: 163–167.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
View this article with LENS
Vol 52 Issue 5 Table of Contents
European Respiratory Journal: 52 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Benefits of supervised community physical activity in obstructive sleep apnoea
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Benefits of supervised community physical activity in obstructive sleep apnoea
Mathieu Berger, Jean-Claude Barthélémy, David Hupin, Jérémy Raffin, Caroline Dupré, Pierre Labeix, Frédéric Costes, Jean-Michel Gaspoz, Frédéric Roche
European Respiratory Journal Nov 2018, 52 (5) 1801592; DOI: 10.1183/13993003.01592-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Benefits of supervised community physical activity in obstructive sleep apnoea
Mathieu Berger, Jean-Claude Barthélémy, David Hupin, Jérémy Raffin, Caroline Dupré, Pierre Labeix, Frédéric Costes, Jean-Michel Gaspoz, Frédéric Roche
European Respiratory Journal Nov 2018, 52 (5) 1801592; DOI: 10.1183/13993003.01592-2018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Association between immunosuppressants and outcomes of COVID-19
Show more Agora

Research letters

  • Mitochondrial DNA as biomarker of survival in RA-ILD
  • Lung transplantation for cystic fibrosis before and after availability of elexacaftor/tezacaftor/ivacaftor
  • Elexacaftor-tezacaftor-ivacaftor and circulating neutrophil counts in CF
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society